Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty

NCT02962362 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2022-09-01

No results posted yet for this study

Summary

Study to collect outcomes data for patients who are undergoing an Exactech Optetrak® primary total knee replacement using the Exactech Guided Personalized Surgery (eGPS®) manufactured or distributed by (Exactech, Gainesville, Florida, USA).

Conditions

Sponsors & Collaborators

  • Exactech

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-07-31
Completion
2021-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02962362 on ClinicalTrials.gov